WallStreetZenWallStreetZen

NASDAQ: CLNN
Clene Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CLNN

Based on 1 analyst offering 12 month price targets for Clene Inc

Min Forecast
$31.00+656.1%
Avg Forecast
$31.00+656.1%
Max Forecast
$31.00+656.1%

Should I buy or sell CLNN stock?

Based on 1 analyst offering ratings for Clene Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CLNN's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates CLNN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their CLNN stock forecasts and price targets.

CLNN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-10-19

1 of 1

Forecast return on equity

Is CLNN forecast to generate an efficient return?

Company
-374.49%
Industry
30.63%
Market
174.61%
CLNN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CLNN forecast to generate an efficient return on assets?

Company
402.7%
Industry
20.43%
CLNN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CLNN earnings per share forecast

What is CLNN's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$2.56
Avg 2 year Forecast
-$1.78
Avg 3 year Forecast
$2.30

CLNN revenue forecast

What is CLNN's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$254.4k+29.13%
Avg 2 year Forecast
$26.9M+13,569.04%
Avg 3 year Forecast
$197.8M+100,321.32%
CLNN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CLNN revenue growth forecast

How is CLNN forecast to perform vs Biotechnology companies and vs the US market?

Company
859.08%
Industry
29.39%
Market
12.3%
CLNN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CLNN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CLNN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CLNN$4.10$31.00+656.10%Buy
PLRX$0.85N/AN/A
HOWL$1.09N/AN/A
OSTX$1.15$10.00+769.57%Strong Buy
ONCY$0.42$5.00+1,090.48%Buy
View Top Biotech Stocks

Clene Stock Forecast FAQ

Is Clene Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CLNN) stock is to Buy CLNN stock.

Out of 1 analyst, 0 (0%) are recommending CLNN as a Strong Buy, 1 (100%) are recommending CLNN as a Buy, 0 (0%) are recommending CLNN as a Hold, 0 (0%) are recommending CLNN as a Sell, and 0 (0%) are recommending CLNN as a Strong Sell.

If you're new to stock investing, here's how to buy Clene stock.

What is CLNN's earnings growth forecast for 2026-2028?

(NASDAQ: CLNN) Clene's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.95%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.18%.

Clene's earnings in 2026 is -$39,518,000.On average, 7 Wall Street analysts forecast CLNN's earnings for 2026 to be -$32,920,460, with the lowest CLNN earnings forecast at -$35,004,489, and the highest CLNN earnings forecast at -$29,814,974. On average, 7 Wall Street analysts forecast CLNN's earnings for 2027 to be -$22,856,220, with the lowest CLNN earnings forecast at -$43,566,738, and the highest CLNN earnings forecast at -$12,816,392.

In 2028, CLNN is forecast to generate $29,540,016 in earnings, with the lowest earnings forecast at -$7,806,756 and the highest earnings forecast at $83,104,182.

What is CLNN's revenue growth forecast for 2026-2028?

(NASDAQ: CLNN) Clene's forecast annual revenue growth rate of 859.08% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 29.39%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.3%.

Clene's revenue in 2026 is $197,000.On average, 7 Wall Street analysts forecast CLNN's revenue for 2026 to be $3,268,508, with the lowest CLNN revenue forecast at $1,322,112, and the highest CLNN revenue forecast at $5,396,375. On average, 7 Wall Street analysts forecast CLNN's revenue for 2027 to be $345,984,758, with the lowest CLNN revenue forecast at $2,518,309, and the highest CLNN revenue forecast at $841,834,572.

In 2028, CLNN is forecast to generate $2,541,821,327 in revenue, with the lowest revenue forecast at $287,087,174 and the highest revenue forecast at $3,575,098,742.

What is CLNN's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: CLNN) forecast ROA is 402.7%, which is higher than the forecast US Biotechnology industry average of 20.43%.

What is CLNN's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CLNN price target, the average CLNN price target is $31.00, with the highest CLNN stock price forecast at $31.00 and the lowest CLNN stock price forecast at $31.00.

The Wall Street analyst predicted that Clene's share price could reach $31.00 by Oct 19, 2027. The average Clene stock price prediction forecasts a potential upside of 656.1% from the current CLNN share price of $4.10.

What is CLNN's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CLNN) Clene's current Earnings Per Share (EPS) is -$3.50. On average, analysts forecast that CLNN's EPS will be -$2.56 for 2026, with the lowest EPS forecast at -$2.72, and the highest EPS forecast at -$2.32. On average, analysts forecast that CLNN's EPS will be -$1.78 for 2027, with the lowest EPS forecast at -$3.39, and the highest EPS forecast at -$1.00. In 2028, CLNN's EPS is forecast to hit $2.30 (min: -$0.61, max: $6.47).

What is CLNN's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: CLNN) forecast ROE is -374.49%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.